-
-
-
-
-
-
-
Waters Corp. (WAT) Tops Q2 EPS by 4c ; Offers Guidance
-
-
-
-
-
-
-
TD Cowen notes short interest shifts in life science tools stocks
-
-
-
-
-
-
-
Waters receives FDA clearance for at-home cervical cancer screening kit
-
-
-
-
-
-
-
Barclays Resumes Waters Corp. (WAT) at Overweight
-
-
-
-
-
-
-
Waters shareholders approve BD biosciences unit combination
-
-
-
-
-
-
-
KeyBanc: White House GLP-1 Deals Boost Growth Potential for Key Suppliers
-
-
-
-
-
-
-
Stifel Reiterates Hold Rating on Waters Corp. (WAT)
-
483,111 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


